J&J unit gets supplemental FDA OK for hip replacement device

04/29/2013 | MassDevice.com (Boston)

DePuy Orthopaedics, a unit of Johnson & Johnson, has received supplemental premarket approval from the FDA for a 36-millimeter version of its Ceramax Ceramic Total Hip System. The implantable device was first approved in 2010 for noncemented use in adult patients receiving total hip replacements.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ